Literature DB >> 27094859

CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention.

Yi Huang1, Emily B Askew1, Cheryl B Knudson1, Warren Knudson2.   

Abstract

Hyaluronan (HA) plays an essential role in cartilage where it functions to retain aggrecan. Previous studies have suggested that aggrecan is anchored indirectly to the plasma membrane of chondrocytes via its binding to cell-associated HA. However, reagents used to test these observations such as hyaluronidase and HA oligosaccharides are short term and may have side activities that complicate interpretation. Using the CRISPR/Cas9 gene editing approach, a model system was developed by generating HA-deficient chondrocyte cell lines. HA synthase-2 (Has2)-specific single guide RNA was introduced into two different variant lines of rat chondrosarcoma chondrocytes; knockout clones were isolated and characterized. Two other members of the HA synthase gene family were expressed at very low relative copy number but showed no compensatory response in the Has2 knockouts. Wild type chondrocytes of both variants exhibited large pericellular matrices or coats extending from the plasma membrane. Addition of purified aggrecan monomer expanded the size of these coats as the proteoglycan became retained within the pericellular matrix. Has2 knockout chondrocytes lost all capacity to assemble a particle-excluding pericellular matrix and more importantly, no matrices formed around the knockout cells following the addition of purified aggrecan. When grown as pellet cultures so as to generate a bioengineered neocartilage tissue, the Has2 knockout chondrocytes assumed a tightly-compacted morphology as compared to the wild type cells. When knockout chondrocytes were transduced with Adeno-ZsGreen1-mycHas2, the cell-associated pericellular matrices were restored including the capacity to bind and incorporate additional exogenous aggrecan into the matrix. These results suggest that HA is essential for aggrecan retention and maintaining cell separation during tissue formation. Copyright Â
© 2016 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggrecan; Chondrocytes; Hyaluronan; Hyaluronan synthase-2

Mesh:

Substances:

Year:  2016        PMID: 27094859      PMCID: PMC5065400          DOI: 10.1016/j.matbio.2016.04.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  59 in total

1.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination.

Authors:  Eugenia Karousou; Masaru Kamiryo; Spyros S Skandalis; Aino Ruusala; Trias Asteriou; Alberto Passi; Hidetoshi Yamashita; Ulf Hellman; Carl-Henrik Heldin; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

3.  Induction of CD44 cleavage in articular chondrocytes.

Authors:  Nobunori Takahashi; Cheryl B Knudson; Sai Thankamony; Wataru Ariyoshi; Liliana Mellor; Hee-Jeong Im; Warren Knudson
Journal:  Arthritis Rheum       Date:  2010-05

Review 4.  Hyaluronan synthases.

Authors:  P H Weigel; V C Hascall; M Tammi
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  CRISPR/Cas9 mediated generation of stable chondrocyte cell lines with targeted gene knockouts; analysis of an aggrecan knockout cell line.

Authors:  Maozhou Yang; Liang Zhang; Jeff Stevens; Gary Gibson
Journal:  Bone       Date:  2014-09-26       Impact factor: 4.398

6.  Antisense inhibition of hyaluronan synthase-2 in human articular chondrocytes inhibits proteoglycan retention and matrix assembly.

Authors:  Y Nishida; C B Knudson; J J Nietfeld; A Margulis; W Knudson
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

7.  Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts.

Authors:  Stephen P Evanko; Susan Potter-Perigo; Loreen J Petty; Gail A Workman; Thomas N Wight
Journal:  Matrix Biol       Date:  2014-12-27       Impact factor: 11.583

8.  Type X collagen is transcriptionally activated and specifically localized during sternal cartilage maturation.

Authors:  P LuValle; K Daniels; E D Hay; B R Olsen
Journal:  Matrix       Date:  1992-11

9.  The formation of human synovial joint cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion.

Authors:  J C Edwards; L S Wilkinson; H M Jones; P Soothill; K J Henderson; J G Worrall; A A Pitsillides
Journal:  J Anat       Date:  1994-10       Impact factor: 2.610

10.  Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenase.

Authors:  C E Clarkin; S Allen; C P Wheeler-Jones; E R Bastow; A A Pitsillides
Journal:  Matrix Biol       Date:  2011-02-01       Impact factor: 11.583

View more
  20 in total

Review 1.  Hyaluronan biology: A complex balancing act of structure, function, location and context.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Matrix Biol       Date:  2019-02-23       Impact factor: 11.583

2.  Chondroprotective effects of 4-methylumbelliferone and hyaluronan synthase-2 overexpression involve changes in chondrocyte energy metabolism.

Authors:  Kenya Terabe; Yoshifumi Ohashi; Saho Tsuchiya; Shinya Ishizuka; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2019-10-16       Impact factor: 5.157

3.  Simvastatin promotes restoration of chondrocyte morphology and phenotype.

Authors:  Kenya Terabe; Nobunori Takahashi; Michelle Cobb; Emily B Askew; Cheryl B Knudson; Warren Knudson
Journal:  Arch Biochem Biophys       Date:  2019-02-15       Impact factor: 4.013

Review 4.  What rheumatologists need to know about CRISPR/Cas9.

Authors:  Gary J Gibson; Maozhou Yang
Journal:  Nat Rev Rheumatol       Date:  2017-02-09       Impact factor: 20.543

Review 5.  Cartilage diseases.

Authors:  Yamini Krishnan; Alan J Grodzinsky
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

Review 6.  The pericellular hyaluronan of articular chondrocytes.

Authors:  Warren Knudson; Shinya Ishizuka; Kenya Terabe; Emily B Askew; Cheryl B Knudson
Journal:  Matrix Biol       Date:  2018-02-06       Impact factor: 11.583

Review 7.  Glycosaminoglycan synthesis in the nucleus pulposus: Dysregulation and the pathogenesis of disc degeneration.

Authors:  Elizabeth S Silagi; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2018-03-01       Impact factor: 11.583

8.  Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan.

Authors:  Shinya Ishizuka; Saho Tsuchiya; Yoshifumi Ohashi; Kenya Terabe; Emily B Askew; Naoko Ishizuka; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2019-07-03       Impact factor: 5.157

Review 9.  Genome Engineering for Personalized Arthritis Therapeutics.

Authors:  Shaunak S Adkar; Jonathan M Brunger; Vincent P Willard; Chia-Lung Wu; Charles A Gersbach; Farshid Guilak
Journal:  Trends Mol Med       Date:  2017-09-05       Impact factor: 11.951

Review 10.  Provisional matrix: A role for versican and hyaluronan.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2016-12-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.